Ads
related to: ceftriaxone for mssa pneumonia infection prevention dose limit age- CDC Recommendation
Visit the Official HCP Website
Learn About CAPVAXIVE™.
- Dosage & Administration
Find CAPVAXIVE™ Dosing Info
Visit Here for More Info.
- Storage and Handling
Visit the Official HCP Website
Access Product Info Here.
- Burden of Disease
CAPVAXIVE™ May be Able to Help
Learn About An Option.
- Indication & Usage
CAPVAXIVE™ is FDA Approved
Learn About An Option Here.
- Stocking Information
Looking to Stock CAPVAXIVE™?
Find NDC Code Here.
- CDC Recommendation
Search results
Results From The WOW.Com Content Network
Cefditoren, also known as cefditoren pivoxil is an antibiotic used to treat infections caused by Gram-positive and Gram-negative bacteria that are resistant to other antibiotics. It is mainly used for treatment of community acquired pneumonia.
Ceftriaxone, sold under the brand name Rocephin, is a third-generation cephalosporin antibiotic used for the treatment of a number of bacterial infections. [4] These include middle ear infections, endocarditis, meningitis, pneumonia, bone and joint infections, intra-abdominal infections, skin infections, urinary tract infections, gonorrhea, and pelvic inflammatory disease. [4]
Pneumonia: Visual disturbance, liver toxicity. [7] Spiramycin: Rovamycine: Mouth infections: Fidaxomicin: Dificid: Treatment of Clostridioides (formerly Clostridium) difficile infection. [8] May be more narrow-spectrum than vancomycin, resulting in less bowel microbiota alteration. [9] Nausea (11%), vomiting, and abdominal pain. [10]
These infections include otitis media, strep throat, pneumonia, urinary tract infections, gonorrhea, and Lyme disease. [5] For gonorrhea typically only one dose is required. [6] In the United States it is a second-line treatment to ceftriaxone for gonorrhea. [5] It is taken by mouth. [5] Common side effects include diarrhea, abdominal pain, and ...
[7] [8] In 2009, ceftaroline had completed phase-III clinical trials for community-acquired pneumonia comparing it against ceftriaxone with non-inferior results and similar adverse reaction profile. [6] However, only results for phase-II clinical trials in treatment of complicated skin and skin structure infections have been published. [12]
The normal four-dose series is given at 2, 4, 6, and 12–14 months of age. In February 2010, a pneumococcal conjugate vaccine that protects against an additional six serotypes was introduced (PCV 13/brand name: Prevnar 13) and can be given instead of the original Prevnar.
The combination of cell destruction and fluid-filled alveoli interrupts the transportation of oxygen into the bloodstream. In addition to their effects on the lungs, many viruses affect other organs. Viral infections weaken the immune system, making the body more susceptible to bacterial infection, including bacterial pneumonia.
In the US, ceftobiprole is indicated for the treatment of adults with Staphylococcus aureus bloodstream infections (bacteremia) including those with right-sided infective endocarditis; [6] adults with acute bacterial skin and skin structure infections; [6] and people with community-acquired bacterial pneumonia. [6] [15] [17]
Ads
related to: ceftriaxone for mssa pneumonia infection prevention dose limit age